-
Nanosyn Inc
Distance: 0.0 Mi3760 Haven Ave
94025-1012 Menlo Park -
Optivia Biotechnology Inc
Distance: 0.3 Mi115 Constitution Dr
94025-1118 Menlo Park -
Genelabs Technologies, Inc.
Distance: 2.2 Mi505 Penobscot Dr
94063 Redwood City -
StemCells, Inc.
Distance: 5.6 Mi3155 Porter Dr
94304 Palo Alto -
Confometrx
Distance: 5.5 Mi840 Chimalus Dr
94306-2602 Palo Alto
Website Links
Description
Nanoscale Combinatorial Synthesis Announces Chemistry Collaboration With ChemDiv Tucson, Ariz., April 19, 1999 /PRNewsire/ Nanoscale Combinatorial Synthesis Inc. (Nanosyn) today announced that ChemDiv, Inc. of San Diego, California and its wholly owned subsidiary Contact Service Company will provide Nanosyn with custom building blocks and large scale synthesis capabilities for lead optimization and preclinical development activities. ''ChemDiv will provide us with a unique source of chemical intermediates for the synthesis of custom libraries for our customers'' notes Dr.
Nanoscale Combinatorial Synthesis and Euroscreen Announce Joint Drug Discovery Collaboration Tucson, Ariz., January 17, 2000/PRNewsire/ Nanoscale Combinatorial Synthesis Inc. (Nanosyn) today announced that it will provide Euroscreen s.a. (Brussels, Belgium) with small molecule libraries designed for discovery research being conducted with Euroscreen's collection of cloned G-protein coupled receptors (GPCRs).
Company Overview Nanosyn is a privately held chemistry-based enterprise founded in 1998 by a group of industry experts specializing in the design, synthesis, and analysis of small molecule organic compounds for the pharmaceutical industry. Our client base consists of pharmaceutical, biotech, and academic institutions. Nanosyn has a well established track record, encompassing well over a hundred business relationships throughout the United States and the rest of the world.
Nanosyn ( www.nanosyn.com ) is a Contract Research Organization providing integrated drug discovery services, medicinal chemistry, made-to-order focused compound libraries, hit-to-lead optimization, assay development, screening and profiling services, process chemistry, and other innovative solutions to meet our partners' drug discovery needs. Founded in 1998, Nanosyn is privately held and self-funding. The company is headquartered in Menlo Park, California with sites in San Diego, California and Research Triangle Park, North Carolina.
Nanoscale Combinatorial Synthesis Announces Combinatorial Chemistry Deal With Caliper Technologies Corp.